About
Protein therapeutics
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
576
By Phase
PHASE3: 1PHASE2: 2PHASE1: 1
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05639192Lead Sponsor
Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease
PHASE3Terminated
34 participants
Started: Nov 3, 2022 · Completed: Aug 18, 2023
NCT04535674Lead Sponsor
Asunercept in Patients With Severe COVID-19
PHASE2Completed
438 participants
Started: Oct 9, 2020 · Completed: Dec 21, 2021
NCT01736436Lead Sponsor
APG101 in Myelodysplastic Syndrome
PHASE1Completed
20 participants
Started: Jan 31, 2013 · Completed: Dec 31, 2015
NCT01071837Lead Sponsor
APG101 in Glioblastoma
PHASE2Completed
84 participants
Started: Dec 31, 2009 · Completed: Oct 31, 2014
Locations (1)
Headquarters
Heidelberg, Germany
Map
Loading map...